Research Reports | Market Assessment
$16,500.00
March 2022

Frontotemporal Dementia – Executive Insights – Frontotemporal Dementia | Executive Insights | (US)

Table of contents

  • Frontotemporal Dementia - Executive Insights - Frontotemporal Dementiau00a0| Executive Insights | (US)
    • Frontotemporal Dementiau00a0 | Executive Insights | US | 2022
Ruchita Kumar, Ph.D.
Ruchita Kumar, Ph.D.

Ruchita Kumar, M.Pharm., Ph.D., is a manager on the CNS/Ophthalmology Disorders team at Clarivate. Her specialties are migraine and Alzheimer’s disease. She has worked on a variety of opportunity assessment and market intelligence projects involving the preparation of disease narratives, epi-based forecasts, and building brand performance reports across different therapy areas. She holds a Ph.D. in the design and development of modified-release dosing forms of antidiabetic drugs from the University Institute of Pharmaceutical Sciences at Panjab University in Chandigarh, India.

Buy report Login to access report
Back to all Market Assessment reports
Buy report
Login to access report

launch Related Market Assessment Reports